ONC-783

N/A

Report date: 2026/03/19 17:18:47

Base Information

Drug NameONC-783
Drug Alias NameONC-783
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-Signal transducer CD24Anti-CD3
TargetsSignal transducer CD24T cell surface glycoprotein CD3
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesOncoc4 Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcroImmune GroupOncoc4 Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A